Free Trial

Lexaria Bioscience (LEXX) SEC Filings & 10K Form

$3.89
-0.10 (-2.51%)
(As of 05/31/2024 ET)

Recent Lexaria Bioscience SEC Filings

DateFilerForm TypeView
05/15/2024
4:37 PM
Carle Vanessa (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
4:16 PM
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
4:24 PM
Carle Vanessa (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
4:03 PM
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
McKechnie William Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
4:11 PM
Baxter Nicholas W (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
3:34 PM
DOCHERTY JOHN MARTIN (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
3:44 PM
BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
1:18 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form D
Notice of Exempt Offering of Securities 
04/30/2024
2:13 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:57 PM
Boos Wayne W (Filed by)
Lexaria Bioscience Corp. (Subject)
Lexaria Bioscience (Subject)
Lexaria Bioscience Corp. (Subject)
Form SC 13D/A
04/24/2024
10:38 AM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
3:12 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/21/2024
3:37 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
11:15 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form EFFECT
03/20/2024
4:00 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 424B3
03/15/2024
3:22 PM
Cabatuan Nelson (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/15/2024
3:09 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
4:09 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/06/2024
5:00 AM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form DEF 14A
03/01/2024
1:28 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:30 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
2:47 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form D
Notice of Exempt Offering of Securities 
02/16/2024
5:01 AM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 424B5
02/14/2024
1:20 PM
Boos Wayne W (Filed by)
Lexaria Bioscience Corp. (Subject)
Lexaria Bioscience (Subject)
Lexaria Bioscience Corp. (Subject)
Form SC 13D/A
02/14/2024
11:00 AM
Invenomic Capital Management LP (Filed by)
Lexaria Bioscience Corp. (Subject)
Lexaria Bioscience (Subject)
Lexaria Bioscience Corp. (Subject)
Form SC 13G/A
01/28/2024
11:15 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form EFFECT
01/24/2024
12:33 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form POS AM
01/18/2024
1:38 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/12/2024
4:11 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/10/2023
11:15 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form EFFECT
12/08/2023
3:31 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 424B3
11/20/2023
4:16 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/03/2023
12:13 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
12:45 PM
Carle Vanessa (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
11:47 AM
DOCHERTY JOHN MARTIN (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2023
11:30 AM
BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
11:25 AM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
12:13 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
2:57 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
11:34 AM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form D
Notice of Exempt Offering of Securities 
10/02/2023
3:06 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 424B5
The Only Energy Play You Should Be Looking At (Ad)

Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.

Click here to get all the information about it.
09/18/2023
9:42 AM
Boos Wayne W (Filed by)
Lexaria Bioscience Corp. (Subject)
Lexaria Bioscience (Subject)
Lexaria Bioscience Corp. (Subject)
Form SC 13D
08/28/2023
1:50 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2023
11:05 AM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form DEF 14A
08/09/2023
11:35 AM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form PRE 14A
07/28/2023
11:11 AM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2023
12:44 PM
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
12:56 PM
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
REESE ALBERT L JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
1:09 PM
Lexaria Bioscience Corp. (Issuer)
Lexaria Bioscience (Issuer)
Lexaria Bioscience Corp. (Issuer)
McKechnie William Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2023
1:42 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/23/2023
3:30 PM
Lexaria Bioscience Corp. (Filer)
Lexaria Bioscience (Filer)
Lexaria Bioscience Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:LEXX) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners